All News
CDC: Impact of Underlying Health Conditions Among COVID-19 Patients
The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections. Below are e
Read Article
Weekly RheumNow Podcast is up! NEW WORLD ORDER; watch it here>> https://t.co/2VDHWoFq28 or listen to the podcast on iTunes or SoundCloud >> https://t.co/ElB9S9nlzY
Links:
Dr. John Cush RheumNow ( View Tweet)
ID Specialist Dr. Jade Le answers questions about COVID - PPE, Masks, Package deliveries, Managing rheum Pts w/ suspicious Sxs, Testing and consulting ID. Watch here>>https://t.co/o79FJ8QhDY or listen on iTunes or here>> https://t.co/7kwcnAmqaA
Links:
Dr. John Cush RheumNow ( View Tweet)
FDA Requests Removal of All Ranitidine (Zantac) from the Market - based on its investigation of the contaminant N-Nitrosodimethylamine (NDMA) in ranitidine; the impurity in ranitidine products increases over time, esp at higher temps https://t.co/BJxLDfpbtS
Dr. John Cush RheumNow ( View Tweet)
Michelle Petri, MD, MPH - Managing Hydroxychloroquine | RheumNow - Rheumatology News & Information https://t.co/eLUR3N3L9m
Dr. John Cush RheumNow ( View Tweet)
RA-BioDAM study from 10 countries and 4356 visits, 571 patients finds T2T practiced in 59% of pts. The benefits of T2T were seen after 3 mos with significantly more remissions at 2 years. https://t.co/Gqrl0ARyzp
Links:
Dr. John Cush RheumNow ( View Tweet)
Using 1987 ACR Criteria, Mayo clinic finds a significant increase in incidence of RF-negative RA and decrease in RF-positive RA in 2005–2014 compared with previous decades. Smoking has decreased and obesity increased in recent years. https://t.co/KZ8DqhOyUe
Links:
Dr. John Cush RheumNow ( View Tweet)
ACR president-elect Dr. David Karp answers questions about hydroxychloroquine and COVID-19; interview, transcript and video. https://t.co/7dRzr1ke89
Dr. John Cush RheumNow ( View Tweet)
RheumNow interviews Dr @philipcrobinson about the rapid growth/impact of the COVID-Global Rheumatology Alliance Registry & how you can join and enroll your rheum patients with suspected COVID. https://t.co/pOlm58QkZD or podcast here> https://t.co/G2otSrIG1U
Links:
Dr. John Cush RheumNow ( View Tweet)
A PODCAST - Rheum Patient PSA on how to manage your arthritis, meds, biologics, misinformation, safety and STRESS in the time of COVID-19 (a 44:01 minute compilation of 5 PSA podcasts) https://t.co/ENrORXRDqz
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow PSA 1 -- How to Manage your Arthritis Medications (in the time of COVID) - View the video here: https://t.co/egUTpxfx96 or listen to the podcast on iTunes or here>> https://t.co/8wV4V2pYY5
Links:
Dr. John Cush RheumNow ( View Tweet)
Listen to Dr. Jack Cush from @RheumNow interview @philipcrobinson about The COVID-19 Global Rheumatology Alliance
https://t.co/aZLsZnAoP3
The COVID-19 Global Rheumatology Alliance rheum_covid ( View Tweet)
Lilly's Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis - https://t.co/kDbNqo2Pii
Drugs.com Drugscom ( View Tweet)
Be careful, QT prolongation is a known effect of chloroquine and hydroxychloroquine. Could be worsened when used with azithromycin. Death and problems reported from France. https://t.co/sKekD9A8Yt
Dr. Janet Woodcock DrWoodcockFDA ( View Tweet)
Survival in lung cancer patients with RA is less than that of those without RA (worse w/ RA-ILD). Study of a cohort 154 lung CA pts (18 with RA,136 without RA) compared propensity matched 18 RA vs 36 without RA and Lung CA. https://t.co/zint9QICE1
Dr. John Cush RheumNow ( View Tweet)
NEJM article on renin-angiotensin-aldosterone inhibitors may increase ACE2 & Covid-19 binding but, "Insufficient data available to determine whether observations translate to humans...no studies have evaluated ...RAAS inhib in Covid-19" https://t.co/x39oCgRTp1
Links:
Dr. John Cush RheumNow ( View Tweet)
#Skin Manifestations in #COVID19.
A very recent article appeared in the @TheJEADV regarding the #dermatological findings in #Covid_19 infection in #Italy.
The authors report that (20.4%) developed cutaneous manifestations. More info ... 👇 #dermatology https://t.co/r1CVcbIUUJ
Dr. Ramon Grimalt DrRamonGrimalt ( View Tweet)
If you want more proof we waste medical school years teaching low value topics (krebs cycle) while failing to teach high value topics (evidence appraisal) then just note how many docs self prescribed hydroxychlorquine and horded it.
Vinay Prasad VPrasadMDMPH ( View Tweet)
Our letter (& color fig!) HCQ in COVID @AnnalsofIM
Great experience writing with @rheum_covid folks, including
@rheum_cat @alhkim @jeffsparks @Larhumato @AliDuarteMD @SituationRheum @pekor002 @SattuiSEMD @emilysirotich @mugartegil @drkatiewebb @Drbeckyg
https://t.co/KzeMXAT6rd https://t.co/dFVW7LyXfR
Mike Putman EBRheum ( View Tweet)
Should Rheum & Derm pts stop biological during #Covid_19? Likely not as a flare may put pts at risk of seeking medical attention or adding steroids. The #outbreak won’t be over for awhile. Ontario Rheum Assoc says take meds unless fever/SOB. J Article review @RheumNow @RheumInfo https://t.co/KDFAq482jt
Janet Pope Janetbirdope ( View Tweet)
